98 related articles for article (PubMed ID: 32467295)
1. Prevalence of
Dong H; Chandratre K; Qin Y; Zhang J; Tian X; Rong C; Wang N; Guo M; Zhao G; Wang SM
J Med Genet; 2021 Aug; 58(8):565-569. PubMed ID: 32467295
[TBL] [Abstract][Full Text] [Related]
2. Population-based BRCA germline mutation screening in the Han Chinese identifies individuals at risk of BRCA mutation-related cancer: experience from a clinical diagnostic center from greater Shanghai area.
Wu Z; Zhang Q; Jin Y; Zhang X; Chen Y; Yang C; Tang X; Jiang H; Wang X; Zhou X; Yu F; Wang B; Guan M
BMC Cancer; 2024 Apr; 24(1):411. PubMed ID: 38566028
[TBL] [Abstract][Full Text] [Related]
3. Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health.
Andaluz S; Zhao B; Sinha S; Lagniton PNP; Costa DA; Ding X; Brito M; Wang SM
BMC Genomics; 2024 Apr; 25(1):416. PubMed ID: 38671360
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa.
ElBiad O; Laraqui A; El Boukhrissi F; Mounjid C; Lamsisi M; Bajjou T; Elannaz H; Lahlou AI; Kouach J; Benchekroune K; Oukabli M; Chahdi H; Ennaji MM; Tanz R; Sbitti Y; Ichou M; Ennibi K; Badaoui B; Sekhsokh Y
BMC Cancer; 2022 Feb; 22(1):208. PubMed ID: 35216584
[TBL] [Abstract][Full Text] [Related]
5. Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients.
Zhang Y; Wu H; Yu Z; Li L; Zhang J; Liang X; Huang Q
BMC Cancer; 2022 Aug; 22(1):842. PubMed ID: 35918668
[TBL] [Abstract][Full Text] [Related]
6. The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective.
Dutil J; Golubeva VA; Pacheco-Torres AL; Diaz-Zabala HJ; Matta JL; Monteiro AN
Breast Cancer Res Treat; 2015 Dec; 154(3):441-53. PubMed ID: 26564481
[TBL] [Abstract][Full Text] [Related]
7. What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database.
Ni M; Wang F; Yang A; Shao Q; Xue C; Xia W; Xu F; Lin X; Huang J; Bi X; Hong R; Chen M; Zheng Q; Jiang K; Xie X; Tang J; Wang X; Yuan Z; Wang S; Shi Y; An X
Cancer Med; 2023 Jun; 12(12):13019-13030. PubMed ID: 37096751
[TBL] [Abstract][Full Text] [Related]
8. Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank.
Abul-Husn NS; Soper ER; Odgis JA; Cullina S; Bobo D; Moscati A; Rodriguez JE; ; ; Loos RJF; Cho JH; Belbin GM; Suckiel SA; Kenny EE
Genome Med; 2019 Dec; 12(1):2. PubMed ID: 31892343
[TBL] [Abstract][Full Text] [Related]
9. Ethnic-specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population.
Qin Z; Li J; Tam B; Sinha S; Zhao B; Bhaskaran SP; Huang T; Wu X; Chian JS; Guo M; Kou SH; Lei H; Zhang L; Wang X; Lagniton PNP; Xiao F; Jiang X; Wang SM
Int J Cancer; 2023 Mar; 152(6):1159-1173. PubMed ID: 36385461
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry.
Friebel TM; Andrulis IL; Balmaña J; Blanco AM; Couch FJ; Daly MB; Domchek SM; Easton DF; Foulkes WD; Ganz PA; Garber J; Glendon G; Greene MH; Hulick PJ; Isaacs C; Jankowitz RC; Karlan BY; Kirk J; Kwong A; Lee A; Lesueur F; Lu KH; Nathanson KL; Neuhausen SL; Offit K; Palmero EI; Sharma P; Tischkowitz M; Toland AE; Tung N; van Rensburg EJ; Vega A; Weitzel JN; Collaborators GS; Hoskins KF; Maga T; Parsons MT; McGuffog L; Antoniou AC; Chenevix-Trench G; Huo D; Olopade OI; Rebbeck TR
Hum Mutat; 2019 Oct; 40(10):1781-1796. PubMed ID: 31112363
[TBL] [Abstract][Full Text] [Related]
11. Racial and ethnic variation in BRCA1 and BRCA2 genetic test results among individuals referred for genetic counseling at a large urban comprehensive cancer center.
Abdallah N; Purrington KS; Tatineni S; Assad H; Petrucelli N; Simon MS
Cancer Causes Control; 2023 Feb; 34(2):141-149. PubMed ID: 36370215
[TBL] [Abstract][Full Text] [Related]
12. Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants.
Momozawa Y; Sasai R; Usui Y; Shiraishi K; Iwasaki Y; Taniyama Y; Parsons MT; Mizukami K; Sekine Y; Hirata M; Kamatani Y; Endo M; Inai C; Takata S; Ito H; Kohno T; Matsuda K; Nakamura S; Sugano K; Yoshida T; Nakagawa H; Matsuo K; Murakami Y; Spurdle AB; Kubo M
JAMA Oncol; 2022 Jun; 8(6):871-878. PubMed ID: 35420638
[TBL] [Abstract][Full Text] [Related]
13. Increased Co-Occurrence of Pathogenic Variants in Hereditary Breast and Ovarian Cancer and Lynch Syndromes: A Consequence of Multigene Panel Genetic Testing?
Infante M; Arranz-Ledo M; Lastra E; Abella LE; Ferreira R; Orozco M; Hernández L; Martínez N; Durán M
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232793
[TBL] [Abstract][Full Text] [Related]
14. The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries.
Laitman Y; Friebel TM; Yannoukakos D; Fostira F; Konstantopoulou I; Figlioli G; Bonanni B; Manoukian S; Zuradelli M; Tondini C; Pasini B; Peterlongo P; Plaseska-Karanfilska D; Jakimovska M; Majidzadeh K; Zarinfam S; Loizidou MA; Hadjisavvas A; Michailidou K; Kyriacou K; Behar DM; Molho RB; Ganz P; James P; Parsons MT; Sallam A; Olopade OI; Seth A; Chenevix-Trench G; Leslie G; McGuffog L; Marafie MJ; Megarbane A; Al-Mulla F; Rebbeck TR; Friedman E
Hum Mutat; 2019 Nov; 40(11):e1-e23. PubMed ID: 31209999
[TBL] [Abstract][Full Text] [Related]
15. Using species richness calculations to model the global profile of unsampled pathogenic variants: Examples from BRCA1 and BRCA2.
Rao ND; Shirts BH
PLoS One; 2023; 18(2):e0278010. PubMed ID: 36753473
[TBL] [Abstract][Full Text] [Related]
16. Clinical Variant Classification: A Comparison of Public Databases and a Commercial Testing Laboratory.
Gradishar W; Johnson K; Brown K; Mundt E; Manley S
Oncologist; 2017 Jul; 22(7):797-803. PubMed ID: 28408614
[TBL] [Abstract][Full Text] [Related]
17. Understanding of BRCA VUS genetic results by breast cancer specialists.
Eccles BK; Copson E; Maishman T; Abraham JE; Eccles DM
BMC Cancer; 2015 Nov; 15():936. PubMed ID: 26608569
[TBL] [Abstract][Full Text] [Related]
18. The review of genetic screening services and common BRCA1/2 variants among South African breast cancer patients.
Makhetha M; Walters S; Aldous C
J Genet Couns; 2024 Jun; 33(3):481-492. PubMed ID: 37528630
[TBL] [Abstract][Full Text] [Related]
19. The economic value of knowing BRCA status: universal BRCA testing for breast cancer prevention.
Oh M; McBride A; Bhattacharjee S; Slack M; Jeter J; Abraham I
Expert Rev Pharmacoecon Outcomes Res; 2023 Mar; 23(3):309-316. PubMed ID: 36637419
[TBL] [Abstract][Full Text] [Related]
20. Chinese American and Non-Hispanic White Breast Cancer Patients' Knowledge and Use of BRCA Testing.
Wang H; Chen LS; Hsiao HY; Hsiao SC; Han T; Chang E; Assoumou B; Wang JH
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
